If it was such a great product Endo would have kept promoting it since Opana is going generic...moot point as it laid off pain team. Look at pain market...all is in a decline and most managedcare is paying for generic 1st...copay cards are going to get you in trouble with opioids
There are plenty of data to support these claims. Docs know it...but patients still clamor for their Oxys